3//SEC Filing
HBM BioCapital II LP 3
Accession 0001179110-17-013643
CIK 0001624658other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 9:36 PM ET
Size
5.9 KB
Accession
0001179110-17-013643
Insider Transaction Report
Form 3
HBM BioCapital II LP
10% Owner
Holdings
Series C Convertible Preferred Stock
→ Common Stock (140,841 underlying)Series B Convertible Preferred Stock
→ Common Stock (1,426,061 underlying)
Footnotes (2)
- [F1]The Series B Convertible Preferred Stock is convertible into Common Stock of the Issuer on a 4.174-to-1 basis at any time at the holder's election, and has no expiration. The Series B Convertible Preferred Stock will automatically convert into Common Stock of the Issuer upon the closing of the Issuer's initial public offering.
- [F2]The Series C Convertible Preferred Stock is convertible into Common Stock of the Issuer on a 4.174-to-1 basis at any time at the holder's election, and has no expiration. The Series C Convertible Preferred Stock will automatically convert into Common Stock of the Issuer upon the closing of the Issuer's initial public offering.
Documents
Issuer
Allena Pharmaceuticals, Inc.
CIK 0001624658
Entity typeother
Related Parties
1- filerCIK 0001721496
Filing Metadata
- Form type
- 3
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 9:36 PM ET
- Size
- 5.9 KB